指南与共识临床生化质量管理与危急值

溶血样本临床化学检测的实用管理建议

Practical recommendations for managing hemolyzed samples in clinical chemistry testing.
指南 / 共识 · Clin Chem Lab Med · 2018-01-01

本建议针对成人及较大儿童溶血样本的临床化学检测结果管理提出实用框架,强调自动测定溶血指数(H-index)以平衡数据质量与临床时效。依据H-index对应分析物偏差是否超过分析显著偏差或参考变化值(RCV),决定结果可发布、附带评论发布或抑制发布并建议重采样;当H-index对应无细胞血红蛋白≥10 g/L时,所有数据均不可靠。不推荐使用校正公式调整溶血敏感检测数据。

要点

  • 建议自动测定血清或血浆溶血指数(H-index),低质量评估不如肉眼检查。
  • H-index对应偏差未达分析显著时可直接发布结果。
  • 偏差在分析与临床显著之间且未超RCV时,可发布并评论提示可能方向及建议重采。

核心结论

  • 基于H-index分层管理溶血样本的临床化学检测结果,避免发布受溶血显著影响的数据并建议重采样。
  • 不推荐使用校正公式调整溶血敏感检测数据。

研究设计与样本

  • 本文为临床化学检验实践建议,针对成人及较大儿童溶血样本的结果管理提出分层策略。

主要发现

  • 自动测定H-index优于低质量评估或肉眼检查。
  • H-index对应偏差未达分析显著时可发布结果。
  • 偏差在分析与临床显著之间且未超RCV时可发布并附评论。
  • 偏差超RCV时抑制溶血敏感结果并附评论建议重采。
  • H-index对应无细胞血红蛋白≥10 g/L时抑制所有数据并建议重采。

关键数值与推荐

  • H-index对应分析物变异未达分析显著偏差:发布结果。
  • H-index对应变异在分析与临床显著偏差之间且未超RCV:发布溶血敏感结果并评论提示可能变化方向及建议重采。
  • H-index对应变异超RCV:抑制溶血敏感结果并评论样本分析前受损、建议重采。
  • H-index对应无细胞血红蛋白≥10 g/L:抑制所有数据并评论样本严重溶血、建议重采。

临床怎么用

  • 实验室应自动测定血清或血浆H-index并据此分层处理溶血样本结果。
  • 依据H-index对应偏差与RCV关系决定结果发布、评论或抑制,并建议重采样。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We suggest here a pragmatic approach for managing results of clinical chemistry testing in hemolyzed samples collected from adults/older children, attempting to balance the need to produce quality laboratory data with clinical urgency of releasing test results. Automatic measurement of the hemolysis index (H-index) in serum or plasma is highly advisable, whilst low-quality assessment of this test remains less good than a visual inspection. Regarding its practical use, when the H-index value does not generate an analytically significant bias, results can be released, whilst when the value is associated with analyte variation in a range between analytically and clinically significant bias (i.e. variation does not exceed the reference change value [RCV]), results of hemolysis-sensitive tests can be released in association with a comment describing the direction in which data are potentially altered, suggesting the need to collect another sample. When the H-index is associated with analyte variation exceeding clinically significant bias (i.e. variation exceeds the RCV), results of hemolysis-sensitive tests should be suppressed and replaced with a comment that biased results cannot be released because the sample is preanalytically compromised and advising the recollection of another sample. If H-index values reach an even higher critical cut-off (i.e. H-index corresponding to a cell-free hemoglobin concentration ≥10 g/L), all laboratory data may be unreliable and should hence be suppressed and replaced with a comment that all data cannot be released because the sample is grossly hemolyzed, also suggesting the recollection of another sample. Due to inaccuracy and imprecision, the use of corrective formulas for adjusting data of hemolysis-sensitive tests is discouraged.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Lippi G, Cadamuro J, von Meyer A, et al. Practical recommendations for managing hemolyzed samples in clinical chemistry testing. Clin Chem Lab Med. 2018. PMID: 29373316. doi:10.1515/cclm-2017-1104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。